Additional studies have highlighted a role for IL17 in inducing EMT via STAT3 activation, while pharmacologic STAT3 inhibition or siRNA knock-down reduces IL17-induced EMT in A549 NSCLC cells [190]. Here, IL17A is linked to non-small cell lung carcinoma.